COMPANY PROFILE / #1239
Arbor Biotechnologies
Cambridge, MAVenture Capital-Backed
OVERVIEW
Developer of gene editing therapeutics designed to treat genetic diseases through precision DNA modification. The company integrates programmable nucleases, delivery engineering, and computational design to enable targeted editing of specific genomic loci, incorporates modular systems for guide selection, payload optimization, and delivery via viral and non-viral vectors across multiple tissue types, and advances a pipeline of in vivo and ex vivo therapeutic candidates addressing rare and common conditions, providing biotechnology and pharmaceutical sectors with scalable approaches for precise genetic intervention and durable disease modification.
已融资304.50
最新估值238.90
员工数103
成立年份2016
公司概况
- Companies
- Arbor Biotechnologies
- Description
- Developer of gene editing therapeutics designed to treat genetic diseases through precision DNA modification. The company integrates programmable nucleases, delivery engineering, and computational design to enable targeted editing of specific genomic loci, incorporates modular systems for guide selection, payload optimization, and delivery via viral and non-viral vectors across multiple tissue types, and advances a pipeline of in vivo and ex vivo therapeutic candidates addressing rare and common conditions, providing biotechnology and pharmaceutical sectors with scalable approaches for precise genetic intervention and durable disease modification.
- Website
- www.arbor.bio
- HQ Location
- Cambridge, MA
- Year Founded
- 2016
- Keywords
- biodiscovery product, diagnostic development, dna sequencing, fermented protein, gene editing, gene therapy, human diagnostic, protein production
- Competitors
- Metagenomi Therapeutics, Intellia Therapeutics, Mammoth Biosciences, Editas Medicine, Scribe
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 304.50
- First Financing Date
- 02-Aug-2017
- First Financing Size
- 15.60
- First Financing Valuation
- 35.60
- Last Financing Date
- 10-Nov-2025
- Last Financing Deal Type
- Accelerator/Incubator
- Last Financing Size
- —
- Last Financing Valuation
- —
- Last Financing Status
- Completed
- Last Known Valuation
- 238.90
- Last Known Valuation Date
- 30-Oct-2025
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 298.59
- Valuation Estimate Growth Rate
- 24.99%
- Active Investors
- Aberdeen Investments (Scotland), Alexandria Venture Investments, Ally Bridge Group, ARCH Venture Partners, ArrowMark Partners, Cure Experience Services, Deep Track Capital, Faridan, GreatPoint Ventures, Illumina Ventures, Industrial Liaison Program, Janus Henderson Investors, Kerna Ventures, Logos Capital, Ono Venture Investment, Partners Investment, Piper Sandler, Qatar Investment Authority, Revelation Partners, Ridgeback Capital, S32, Samsung Bioepis, Samsung Venture Investment, Surveyor Capital, T. Rowe Price Group, Tao Capital Partners, TCG Crossover Management, Temasek Holdings, Vertex Pharmaceuticals, Woodline Partners
- # Active Investors
- 30
- Acquirers
- —
团队与联系人
- Employees
- 103
- Employee Growth %
- -6.36%
- Employee History
- 2026: 103, 2025: 110, 2024: 121, 2023: 152, 2022: 120, 2021: 60, 2020: 40, 2019: 40
- Primary Contact
- David Walt
- Primary Contact Title
- Co-Founder & Board Member
- Primary Contact Email
- dwalt@arbor.bio
- Primary Contact Phone
- +1 (857) 301-6366
增长与经营
- Revenue
- 35.00
- Revenue Growth %
- —
- Growth Rate
- 2.42%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 100
- Size Multiple
- 12.84x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 95
- Majestic Referring Domains
- 185
- SimilarWeb Unique Visitors
- 2,134
- SimilarWeb Unique Visitors Change
- 117
- SimilarWeb Growth Rate
- 9.67%
- SimilarWeb Growth Rate Percentile
- 100
- Success Probability Over Time – 1 Year
- 38%
- Success Probability Over Time – 3 Year
- 61%
- Success Probability Over Time – 5 Year
- 71%
记录来源：public.companies · 原始序号 #1239 · 所有字段均按数据库原值展示。